Granit V, Benatar M, Kurtoglu M, Miljkovic MD, et al. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study. Lancet Neurol 2023;22:578-590.
PMID: 37353278